COMMUNIQUÉS West-GlobeNewswire

Surface Oncology Presents Preclinical Data Further Supporting Anti-Tumor Mechanism of CD73 and CD39 Programs at Brisbane Immunotherapy 2019
24/05/2019
Presentation provides updated in vivo efficacy data supporting adenosine reduction for cancer treatment Data also support anti-CD39 candidate’s capability to invoke both innate and adaptive immune anti-tumor activity [...]
Virbac: communiqué précisant les modalités de mise à disposition ou de consultation des documents préparatoires à l'Assemblée Générale
24/05/2019
Le 24 mai 2019 Communiqué précisant les modalités de mise à disposition ou de consultation des documents préparatoires à l’assemblée générale Les actionnaires de VIRBAC sont convoqués en assemblée générale ordinaire et [...]
Bone Therapeutics to present data at TERMIS European Chapter Meeting 2019
24/05/2019
Press release Gosselies, Belgium, 24 May 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, [...]
Bone Therapeutics présentera des données au congrès européen TERMIS 2019
24/05/2019
Communiqué de presse Gosselies, Belgique, le 24 mai 2019, 7am CEST – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux non [...]
Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 12 June 2019 have been made available
24/05/2019
Regulated information Gosselies, Belgium, 24 May 2019, 7 am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Mise à disposition des documents préparatoires à l’assemblée générale extraordinaire du 12 juin 2019
24/05/2019
Information réglementée Gosselies, Belgique, le 24 mai 2019, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux [...]
Immuron Prices Underwritten Public Offering of ADSs
24/05/2019
MELBOURNE, Australia,, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for [...]
Nova Leap Health Corp. Posts Record Financial Results for First Quarter 2019
23/05/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 23, 2019 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a 2019 [...]
Galectin Therapeutics Reports Alternate Price of Common Stock in Rights Offering
23/05/2019
NORCROSS, Ga., May 23, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported the Alternate Price (i.e., the final [...]
UPDATE - New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study And “CBD International Consortium” to Develop Treatment of Opioid Addiction
23/05/2019
MediPharm Labs enters major U.S. led opioid clinical research trial to develop IP and exclusively manufacture CBD gelcaps TORONTO, May 23, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: [...]
Acasti Issues Shares in Settlement of Claims with Former Chief Executive Officer
23/05/2019
LAVAL, Québec, May 23, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST) announced that it has completed the previously disclosed issuance of 900,000 common shares from [...]
Immuron Announces Proposed Public Offering of ADSs
23/05/2019
MELBOURNE, Australia, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the [...]
Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business
23/05/2019
Company will explore strategic alternatives for its immuno-oncology programs Company will align its resources to focus on HEPLISAV-B commercialization Eddie Gray, CEO, to retire BERKELEY, Calif., May 23, 2019 (GLOBE [...]
WW Announces Participation in Upcoming Investor Conferences
23/05/2019
NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (Nasdaq: WW), a global wellness company and the world’s leading commercial weight management program, today announced that Nick Hotchkin, [...]
Neuronetics to Present at the William Blair 39th Annual Growth Stock Conference
23/05/2019
MALVERN, Pa., May 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for [...]
The Cooper Companies to Participate in the Raymond James Life Sciences and MedTech Conference
23/05/2019
PLEASANTON, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will participate in the Raymond James Life Sciences and MedTech Conference in New York, NY, on June 18, 2019. Albert G. White [...]
Ziopharm Oncology Presentation at the Jefferies 2019 Global Healthcare Conference to be Webcast
23/05/2019
BOSTON, May 23, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP), a clinical stage immuno-oncology company developing next generation cell and gene therapies, today announced that Laurence Cooper, M.D., [...]
AIT Therapeutics Participating at the Oppenheimer MedTech Day on May 29
23/05/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, May 23, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
New clinical data demonstrates the versatility of Globus Medical’s ExcelsiusGPS®
23/05/2019
Study reviews 100 cases demonstrating 99% pedicle screw placement success rate AUDUBON, Pa., May 23, 2019 (GLOBE NEWSWIRE) -- Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company today announced the [...]

Pages